ZYMEWORKS INC (ZYME:NASDAQ)
$28.27 0.42 (1.5081%)
Analysed ZYMEWORKS INC (ZYME:NASDAQ) News Sources
Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026
21-04-2026
yahoo.com
Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform
17-04-2026
yahoo.com
How Investors May Respond To Zymeworks (ZYME) Hiring EcoR1 Executives To Lead R&D And Deals
17-04-2026
yahoo.com
Jazz Pharmaceuticals Touts Record $4.3B 2025 Revenue, Reaffirms 2026 Outlook at Conference
16-04-2026
marketbeat.com
Zymeworks to Report First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026
16-04-2026
yahoo.com
Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth
09-04-2026
yahoo.com
Exchange-Traded Funds, Equity Futures Gain Pre-Bell Wednesday as Iran War De-Escalation Hopes Drive Sentiment
01-04-2026
yahoo.com
Zymeworks Appoints Kristin Stafford as Chief Financial Officer
01-04-2026
yahoo.com
How Investors May Respond To Zymeworks (ZYME) Fast Track Nod For Ovarian Cancer ADC ZW191
31-03-2026
yahoo.com
Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate
30-03-2026
yahoo.com
What is the current price of ZYMEWORKS INC (ZYME:NASDAQ)?
The current price of ZYMEWORKS INC (ZYME:NASDAQ) is $28.27.
ZYMEWORKS INC (ZYME:NASDAQ) absolute price change since previous trading day?
The absolute price change of ZYMEWORKS INC (ZYME:NASDAQ) since the previous trading day is $0.42.
ZYMEWORKS INC (ZYME:NASDAQ) percentage price change since previous trading day?
The percentage price change of ZYMEWORKS INC (ZYME:NASDAQ) since the previous trading day is 1.5081%.
What is the most recent average sentiment score for ZYMEWORKS INC (ZYME:NASDAQ)?
The most recent average sentiment score for ZYMEWORKS INC (ZYME:NASDAQ) is 87 out of 100.
What is the most recent average sentiment for ZYMEWORKS INC (ZYME:NASDAQ)?
The most recent sentiment for ZYMEWORKS INC (ZYME:NASDAQ) is .
SEC-8K** Filing Available For ZYMEWORKS INC (ZYME:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.